MarketFriction

Tatva Chintan Pharma Chem Ltd

NSE TATVA · BSE 543321 · Specialty Chemicals
₹1,743.20 -2.30%
NSE close2026-10-01
52 week range992.30 - 1,880.00
Market cap₹4,223 Cr.
P/E80.6
IPO 2021 · +61% since ASM long-term Price band 20% Delivery 45.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9784981058386108117124131134167
Expenses76738393787999100101106106135
Operating Profit201116136791722252832
OPM %21%13%16%12%7%8%8%15%18%19%21%19%
Other Income1151001112-01
Interest300000001012
Depreciation77677779991011
Profit before tax115147-1-02914181721
Tax %31%34%30%24%-34%-165%49%27%27%14%38%24%
Net Profit83105-101710151016
EPS in Rs3.331.484.112.23-0.280.060.442.844.246.494.416.83
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales136206263300434424394383506556
Expenses113172208234325363325348412448
Operating Profit2334556710961693594108
OPM %17%17%21%22%25%14%17%9%18%19%
Other Income1115927234
Interest3444597235
Depreciation345781026283738
Profit before tax19274861104454485769
Tax %35%25%21%14%8%-2%30%25%26%
Net Profit1221385296453064251
EPS in Rs15.3025.5647.0326.0243.2520.5212.972.4417.9821.97
Dividend Payout %0%0%0%19%5%10%15%41%11%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%11%6%41%
Compounded Profit Growth%-4%-5%632%
Stock Price CAGR%-4%5%82%
Return on Equity%8%4%6%
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital888202222232323
Reserves5172110146451493714715758
Borrowings567791901201701436120
Other Liabilities2831415965746761102
Total Liabilities1441882493156587598198361,004
Fixed Assets5767111120160196427529609
CWIP10651051231772425
Investments1000001004
Other Assets76115133185447332305283365
Total Assets1441882493156587598198361,004
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity13725202028982531
Cash from Investing Activity-30-17-40-21-197-101-121-65-116
Cash from Financing Activity71710-523538311779
Net Cash Flow-108-5-659-368-24-6
Free Cash Flow-18-2-23-1-69-175-30-51-82
CFO/OP105%39%61%44%36%61%157%85%42%
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days7773691104873658586
Inventory Days148114175173319262320246319
Days Payable12771871148352946095
Cash Conversion Cycle99116157169283283291271310
Working Capital Days15464774742515814892
ROCE %22%28%28%26%9%7%1%7%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters72.02%72.02%72.02%72.02%72.02%72.02%72.02%72.02%72.02%72.02%72.02%72.02%
FIIs4.40%4.21%3.65%3.37%3.33%3.36%3.30%3.26%3.40%4.17%3.81%3.93%
DIIs13.78%13.06%12.84%10.64%6.83%6.34%5.46%5.11%3.87%3.32%2.99%3.11%
Public9.79%10.72%11.49%13.97%17.81%18.27%19.21%19.60%20.72%20.49%21.16%20.94%
No. of Shareholders74,62874,51973,73073,91279,62379,00978,39376,79273,33168,65766,84264,921

Fundamentals

Market Cap₹ 4,223 Cr.
Current Price₹ 1,806
Stock P/E80.6
Book Value₹ 334
ROCE7.18 %
ROE5.54 %
Dividend Yield0.11 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)41%
Compounded Profit Growth (TTM)632%
Consolidated figures.
Valuation
Market capRs 4,078 Cr
Enterprise valueRs 4,100 Cr
P/E (TTM)79.35x
Price to book5.52x
Price to sales7.33x
EV / EBITDA36.61x
EV / EBIT55.75x
EV / sales7.37x
Price to cash flow164.62x
Earnings yield1.26%
Dividend yield0.06%
P/E, 3-year average147.29x
P/B, 3-year average4.25x
P/E, 5-year average123.81x
P/B, 5-year average5.89x
Profitability
Operating margin (excl. other income)9.03%
Operating margin (incl. other income)9.60%
EBITDA margin20.14%
Pre-tax margin12.41%
Net profit margin9.24%
Net margin, latest quarter9.57%
ROE0.77%
ROCE1.19%
ROA0.69%
ROE, 3-year average4.94%
ROCE, 3-year average5.51%
ROA, 3-year average3.65%
ROE, 5-year average16.34%
ROCE, 5-year average14.06%
ROA, 5-year average9.84%
ROIC (approx.)7.28%
Tax rate24.67%
Other income / net worth0.30%
Growth
Sales growth (latest year)-2.74%
Profit growth (latest year)-81.19%
Sales CAGR, 3 years-4.08%
Sales CAGR, 5 years7.77%
Profit CAGR, 3 years-60.95%
Profit CAGR, 5 years-31.47%
Sales growth QoQ24.54%
Profit growth QoQ54.84%
Sales growth YoY (latest quarter)42.96%
Profit growth YoY (latest quarter)140.30%
Per share
EPS (TTM)Rs 21.97
EPS (latest year)Rs 2.44
EPS (latest quarter)Rs 6.83
EPS, 3-year averageRs 11.98
EPS, 5-year averageRs 21.04
Book value per shareRs 315.84
Sales per shareRs 237.71
Cash flow per shareRs 10.59
Free cash flow per shareRs -35.05
Dividend per share (latest year)Rs 1.00
Dividend per share, 3-year averageRs 1.67
Dividend per share, 5-year averageRs 2.40
Dividends
Dividend payout40.98%
Dividend payout, 3-year average22.05%
Dividend payout, 5-year average17.99%
Efficiency
Asset turnover0.46x
Fixed asset turnover0.72x
Inventory turnover1.87x
Inventory days195 days
Debtor days85 days
Debtors turnover4.27x
Creditor days95 days
Cash conversion cycle310 days
Working capital days92 days
Leverage
Total debtRs 36 Cr
Cash and bankRs 14 Cr
Net debtRs 22 Cr
Debt to equity0.05x
Net debt / EBITDA0.20x
Interest coverage16.27x
Current ratio (filing 2026-03-31)1.64x
Quick ratio (filing 2026-03-31)0.72x
Trade payables (filing 2026-03-31)Rs 58 Cr
Owners' fund to total sources88.35%
Debt to assets4.35%
Cash flow
Cash from Operating Activity (latest year)Rs 25 Cr
Cash from Investing Activity (latest year)Rs -65 Cr
Cash from Financing Activity (latest year)Rs 17 Cr
Net Cash Flow (latest year)Rs -24 Cr
Free cash flow (latest year)Rs -82 Cr
FCFE (approx.: FCF + change in debt)Rs -60 Cr
Cash from ops / profit, 5 years0.92x
Sales to cash flow15.45x
Statement figures
Net sales (TTM)Rs 556 Cr
Net sales (latest year)Rs 383 Cr
Sales (latest quarter)Rs 167 Cr
Operating profit excl. other income (latest year)Rs 35 Cr
Operating profit (latest quarter)Rs 32 Cr
Other income (TTM)Rs 4 Cr
EBITDA (TTM)Rs 112 Cr
PBDT (TTM)Rs 107 Cr
Profit before tax (TTM)Rs 69 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 51 Cr
Net profit (latest year)Rs 6 Cr
Net profit (latest quarter)Rs 16 Cr
Depreciation (TTM)Rs 38 Cr
Depreciation (latest quarter)Rs 11 Cr
Interest (TTM)Rs 5 Cr
Cost of goods sold (latest year)Rs 251 Cr
Total expenditure (latest year)Rs 348 Cr
Total income (latest year)Rs 385 Cr
Share capitalRs 23 Cr
ReservesRs 715 Cr
Shareholders' fundsRs 739 Cr
Total assetsRs 836 Cr
Net blockRs 529 Cr
Capital work in progressRs 24 Cr
ReceivablesRs 90 Cr
InventoryRs 134 Cr
Other liabilitiesRs 61 Cr
Shares outstanding (crore)2.34
Ownership
Promoter holding72.02% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 79.3 is at the 44th percentile of its own 5.2-year range (median 87.3, low 25.2, high 392.4).
P/B 5.52 is at the 44th percentile (median 6.01).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodTATVANifty 50Difference
1 week+0.8%-2.8% +3.6 pts
1 month+8.6%-6.8% +15.4 pts
3 months+39.5%-7.6% +47.1 pts
6 months+65.6%+0.4% +65.2 pts
1 year+65.2%-9.9% +75.1 pts
2 years+74.0%-13.6% +87.5 pts
3 years+10.1%+14.2% -4.0 pts
5 years-19.1%+27.9% -47.0 pts
6 mutual fund schemes hold about ₹109 Cr. Over three months 2 bought more and 2 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Nippon India ELSS Tax Saver Fund0.57%84 -1%
ICICI Pru MNC Fund0.60%11 -5%
ICICI Pru Commodities Fund0.22%9 -11%
WOC Pharma and Healthcare Fund0.39%4 +55%
JM Multi Asset Allocation Fund0.63%1 +100%
Motilal Oswal BSE 1000 Index Fund0.01%0

Red flags

F-score 4 of 8
explainReceivables outrunning sales Receivables grew 28% vs sales -3% in 2026
explainDebt up, profit down Borrowings up 155% while net profit fell in 2026
lookOn NSE surveillance On NSE surveillance: ASM long-term
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹167 Cr +42.7% vs Jun 2025. Net profit ₹16 Cr +128.6%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Pidilite Industries Ltd148,80956.231.0 %
Gujarat Fluorochemicals Ltd48,40278.49.64 %
Navin Fluorine International Ltd42,25553.121.0 %
Aether Industries Ltd23,22696.811.9 %
Deepak Nitrite Ltd20,85426.311.4 %
Atul Ltd17,61422.114.9 %
Aarti Industries Ltd17,04532.66.86 %
Fine Organic Industries Ltd15,75936.021.5 %
BASF India Ltd14,87124.014.5 %
Privi Speciality Chemicals Ltd14,08440.322.3 %
Anupam Rasayan India Ltd13,40976.87.38 %
Vinati Organics Ltd12,17324.421.4 %
Elantas Beck India Ltd10,82060.921.2 %
Jubilant Ingrevia Ltd10,18032.011.4 %
Alkyl Amines Chemicals Ltd9,11140.516.6 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-09-11Dividend - Rs 2 Per Share
2025-09-12Dividend - Re 1 Per Share
2024-09-06Dividend - Rs 2 Per Share
2024-09-06Annual General Meeting
2023-09-08Dividend - Rs 2 Per Share
2023-09-08Annual General Meeting
2022-09-08Dividend - Rs 2 Per Share
2022-09-08Annual General Meeting
2021-09-17 Annual General Meeting
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Long Term Additional Surveillance Measure (Long Term ASM): stage 1Scrip PE is greater than 50 (4 trailing quarters)
Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.Updated 2026-10-03